Valiant Laboratories Ltd Falls 5.46%: 2 Key Technical Events Shape the Week

1 hour ago
share
Share Via
Valiant Laboratories Ltd experienced a challenging week on the BSE, closing at Rs.69.80 on 12 Jun 2026, down 5.46% from the previous Friday’s close of Rs.73.83. This decline contrasted with the Sensex’s modest 0.57% gain over the same period, highlighting the stock’s underperformance amid mixed technical signals. The week was marked by a sharp lower circuit hit on 10 Jun and a notable Golden Cross formation on 12 Jun, signalling potential shifts in momentum for this micro-cap pharmaceutical player.

Key Events This Week

8 Jun: Stock opens at Rs.74.79, gains 1.30% despite Sensex decline

9 Jun: Sharp drop of 3.92% amid sector divergence

10 Jun: Hits lower circuit at Rs.69.18 amid heavy selling pressure

11 Jun: Continues decline, closing at Rs.67.18 (-4.03%)

12 Jun: Rebounds 3.90% with Golden Cross technical signal

Week Open
Rs.73.83
Week Close
Rs.69.80
-5.46%
Week High
Rs.74.79
vs Sensex
-6.03%

8 June: Positive Start Amid Market Weakness

Valiant Laboratories began the week on a relatively strong note, closing at Rs.74.79, up 1.30% from the previous close. This gain was notable as the Sensex declined by 1.33% to 34,673.90 on the same day, indicating stock-specific strength. However, the volume was modest at 165 shares, suggesting limited participation. The stock’s resilience contrasted with broader market weakness, but this proved short-lived as subsequent sessions saw increased selling pressure.

9 June: Sharp Decline Amid Sector and Market Divergence

The following day, the stock reversed sharply, falling 3.92% to Rs.71.86 on increased volume of 262 shares. This decline occurred despite the Sensex gaining 0.88%, reflecting an idiosyncratic sell-off. Delivery volumes had already shown signs of waning commitment, foreshadowing the intensified selling that would culminate later in the week. The stock’s underperformance relative to the market and sector peers raised early caution flags for investors.

10 June: Lower Circuit Hit Signals Heavy Selling Pressure

On 10 June, Valiant Laboratories hit its lower circuit limit at Rs.69.18, closing near this intraday low at Rs.69.27. The stock plunged 4.88% intraday, reflecting overwhelming selling interest that outpaced buying demand. Trading volume increased significantly to 993 shares, with turnover of approximately ₹0.0974 crore. This circuit breaker activation underscored panic selling and fragile investor sentiment. The stock’s decline was stark against the Sensex’s modest 0.69% gain, highlighting the stock’s isolated weakness.

Technically, the stock remained above its 50-day and 100-day moving averages but below the 5-day, 20-day, and 200-day averages, indicating short-term bearishness amid a neutral longer-term trend. The Mojo Score stood at 33.0 with a ‘Sell’ rating, upgraded from ‘Strong Sell’ on 8 June, reflecting some stabilisation but continued caution.

11 June: Continued Downtrend on Heavy Volume

Valiant Laboratories extended its losses, closing at Rs.67.18, down 4.03% on a sharp increase in volume to 6,009 shares. The Sensex declined 0.53% on the day, but the stock’s fall was more pronounced, signalling sustained selling pressure. The volume surge suggested intensified liquidation, possibly triggered by stop-losses and lack of fresh buying interest. The stock’s technical position remained weak, with prices below key short-term moving averages, reinforcing the bearish momentum.

Under the radar no more! This Large Cap from Cement is emerging from turnaround with solid fundamentals intact. Discover it while it's still relatively hidden!

  • - Hidden turnaround gem
  • - Solid fundamentals confirmed
  • - Large Cap opportunity

Discover This Hidden Gem →

12 June: Golden Cross Formation Sparks Rebound

On the final trading day of the week, Valiant Laboratories rebounded strongly, gaining 3.90% to close at Rs.69.80 on volume of 1,468 shares. This recovery coincided with a significant technical event: the formation of a Golden Cross, where the 50-day moving average crossed above the 200-day moving average. This classic bullish indicator suggests a potential shift in long-term momentum and possible trend reversal.

Supporting this positive signal, the weekly MACD and On-Balance Volume (OBV) indicators showed bullish momentum, while the Bollinger Bands and Know Sure Thing (KST) indicators presented mixed signals. The Relative Strength Index (RSI) remained neutral, indicating no immediate overbought or oversold conditions. Despite the recent 1-year return of -41.48%, the stock’s 3-month gain of 29.16% and year-to-date outperformance relative to the Sensex hint at emerging resilience.

Valiant Laboratories Ltd or something better? Our SwitchER feature analyzes this micro-cap stock and recommends superior alternatives based on fundamentals, momentum, and value!

  • - SwitchER analysis complete
  • - Superior alternatives found
  • - Multi-parameter evaluation

See Smarter Alternatives →

Daily Price Performance vs Sensex

Date Stock Price Day Change Sensex Day Change
2026-06-08 Rs.74.79 +1.30% 34,673.90 -1.33%
2026-06-09 Rs.71.86 -3.92% 34,979.26 +0.88%
2026-06-10 Rs.70.00 -2.59% 34,766.59 -0.61%
2026-06-11 Rs.67.18 -4.03% 34,580.95 -0.53%
2026-06-12 Rs.69.80 +3.90% 35,342.50 +2.20%

Key Takeaways

Positive Signals: The Golden Cross formation on 12 June is a significant technical milestone, often signalling a shift to bullish momentum. Supporting indicators such as weekly MACD and OBV reinforce this potential trend reversal. The stock’s 3-month and year-to-date relative outperformance versus the Sensex also suggest emerging resilience despite recent weakness.

Cautionary Signals: The week’s overall 5.46% decline contrasts sharply with the Sensex’s 0.57% gain, reflecting stock-specific challenges. The lower circuit hit on 10 June and sustained selling pressure through 11 June highlight fragile investor sentiment and technical weakness. The Mojo Score remains at 33.0 with a ‘Sell’ rating, indicating ongoing caution. Mixed technical indicators and a negative 1-year return of -41.48% underscore the stock’s volatility and risk profile.

Volume and Liquidity: Trading volumes fluctuated, peaking on 11 June with 6,009 shares traded, signalling heightened liquidation. The rebound on 12 June was supported by increased volume, suggesting some renewed buying interest, but overall liquidity remains modest given the micro-cap status.

Conclusion

Valiant Laboratories Ltd’s week was defined by volatility and contrasting technical signals. The sharp decline culminating in a lower circuit hit reflected intense selling pressure and investor caution. However, the formation of a Golden Cross on the final trading day offers a potential turning point, signalling a possible shift in momentum. Despite this, the stock’s underperformance relative to the Sensex and mixed technical indicators counsel prudence. Investors should closely monitor subsequent price action, volume trends, and fundamental developments to assess whether the bullish signal can be sustained amid the stock’s inherent volatility and micro-cap risks.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News